- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
The Biotechnology Industry Organization (BIO) invites leaders in science, finance, business, law, and government policy to submit proposals for breakout sessions at the 2008 BIO International Convention to be held June 17-20 at the San Diego Convention Center. The day pattern will change from previous years to Tuesday-Friday.
The BIO International Convention continues to be the number one resource for the latest information and the newest opportunities for executives, investors, scientists, policy leaders, and journalists from around the world. Speakers at the sessions will share breakthroughs in medicine, diagnostics, the environment, energy production, food and agriculture, and more with a global audience of an estimated 24,000 attendees.
The convention will feature more than 200 breakout sessions in 21 educational session tracks, including biodefense; bioethics; clinical research/clinical trials; devices and diagnostics; drug discovery and development; emerging company issues; finance; food and agriculture; industrial and environmental; intellectual property/legal; manufacturing; nanotechnology; technology transfer/licensing and other key business areas for doing biotech business globally.
The most popular educational tracks from the 2007 BIO International Convention included business development, clinical research, devices and predictive diagnostics and technology transfer. Super Sessions, Biotech Entrepreneurship Boot Camp and the Translational Research Forum all drew significant attendance.
Applications for educational sessions will only be accepted online, at http://www.bio2008.org/Attendees/program.html. The online application process closes on Friday, September 7th at 5:00 pm EDT.
All proposals will be reviewed by BIO staff, the standing BIO Program Committee and a local Program Committee composed of biotechnology professionals. Applicants will be notified of the status of their session proposal beginning early November 2007.
The 2007 BIO International Convention drew a record 22,366 attendees, a nearly 15 percent increase from the previous year, with representatives from 48 states and one-third of attendees from outside the United States.
About Biotechnology Industry Organization (BIO)
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the annual BIO International Convention, the global event for biotechnology.
Upcoming BIO Events
-- BIO VentureForum-East 2007
June 18-20, 2007
-- BIO Mid-America VentureForum 2007
Sept. 24-26, 2007
-- BIO InvestorForum 2007
Oct. 9-11, 2007
San Francisco, Calif.
-- BIO-Europe 2007 International Partnering Conference
Nov. 12-14, 2007
-- Pacific Rim Summit on Industrial Biotechnology and Bioenergy
Nov. 14-17, 2007
For more information, please click here
Biotechnology Industry Organization (BIO)
Copyright © Business Wire 2007If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Lehigh engineer discovers a high-speed nano-avalanche: New findings published in the Journal of Electrochemical Society about the process involving transformations in glass that occur under intense electrical and thermal conditions could lead the way to more energy-efficient glas August 24th, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Research team led by NUS scientists develop plastic flexible magnetic memory device: Novel technique to implant high-performance magnetic memory chip on a flexible plastic surface without compromising performance July 21st, 2016
Nanoparticles that speed blood clotting may someday save lives August 23rd, 2016
Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016 August 16th, 2016